The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.The Organs-on-chips Market  is expected to reach USD 45.6 million by 2022 from USD 9.6 million in 2017, at a CAGR of 36.6%.Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144117291Market Segmentation: -Based on type, the organs-on-chips market is segmented into liver, lung, heart, kidney, and other organs-on-chips.

In 2017, the accessories segment is expected to account for the largest share of the organs-on-chips market.

The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.Based on application, the organs-on-chips market is segmented into physiological model development, drug discovery, and toxicology research.

The drug discovery segment is expected to register the highest CAGR during the forecast period.

The increasing focus on drug discovery, rising need for more predictive in vitro tools for drug development among pharmaceutical companies, and growing preference for alternatives to conventional cell culture and animal models are some of the factors that are driving the growth of the drug discovery segment.Key Market Drivers :- 1 Growing Focus on Developing Alternatives for Animal Testing Models 2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips 3 Technological Advancements and New Products Launches 4 Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Organs-on-Chips Manufacturers 5 Growing Need for Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late Stage Drug Failure 6 Growing Initiatives to Increase Awareness About Organs-on-Chips TechnologiesRegional Analysis: -In 2017, North America is expected to dominate the market followed by Europe.

The large share of this geographical segment is attributed to factors such as availability of new and advanced organs-on-chips in the market.Request for Sample Pages  - https://www.marketsandmarkets.com/requestsampleNew.asp?id=144117291  Top key Players:-The organs-on-chips market is emerging and high growth potential market with the presence of several small players and startups firms.

Artificial Organs Market Overview:Artificial organ is an engineered device, machine, tissue or others material that is implanted or integrated into a human body to replace the functions of a missing organ.

Artificial organ helps to prevent imminent death while awaiting a transplant and improving the patient’s capability to interact socially.

Now these days, use of the artificial organ is increasing globally due to its technological advancement and growing demand for patient care.Our report studies Artificial Organs market and covers historical and forecast data for application, regional and country.Top playersEsko BionicsF Hoffman-La Roche LtdGambro ABIwalk Inc.Jarvik HeartLifenet HealthMedtronicNano Retina, Inc.OthersAlong with these leading players, there are a number of other small and mid-sized players who are coming with huge investment and innovative product launch in the Artificial Organs industry.Get More Details @ https://brandessenceresearch.com/biotechnology/global-artificial-organs-marketMarket SegmentationBy Product TypeVision BionicsEar BionicsOrthopedic BionicsHeart BionicsOthersBased upon application segment, Prescription Sleep Aids product type segment has a significant market share in a historic year and it is expected to maintain its dominance in the forecast period.By Technology TypeMechanicalElectronicBased on Technology segment, Mechanical technological type segment has a significant market share in a historic year and it is expected to maintain its dominance in the forecast period.Key Benefits for Artificial Organs Market ReportsThe analysis provides an exhaustive investigation of the global Post-Consumer Artificial Organs market together with the future projections to assess the investment feasibility.

The report also comprehends business opportunities and scope for expansion.

This is done with an aim of helping companies inKey Reasons To Purchase Artificial Organs Market Report:To gain insightful analyses of the marketAssess the production processesTo understand the most affecting driving and restrainingMarket strategies by leading respective organizations.To understand the future outlook and prospects for the marketEach company profiled in the research document is studied considering various factors such as product and its application portfolios, market share, growth potential, future plans, and development activity.

Readers will be able to gain complete understanding and knowledge of the competitive landscape.

Medical Device in this field from last past few decades, technology has worked closely with medicine for advancements in the field of pharmaceuticals and the medical field in general to save millions of lives.

Bluetooth-enable smart inhalers, robotic surgery, wireless brain sensors, 3-D printers, artificial organs and health wearable are some of the medical devices that have taken the medical world by storm.

The Global Vital Organs Support Systems and Medical Bionics Market size was valued at USD 33.88 billion in 2019 and is predicted to reach USD 93.80 billion by 2030, with a CAGR of 9.7% from 2020-2030.The Organ Support System comprises of artificial organs that are designed to perform the function of natural human organs, and are utilized as a substitute of lost body organ, replacement of the damaged organ, and as a support to the existing organs.

These benefits are expected to supplement the growth of vital organs support systems and medical bionics market.Access Full Description of this report at:-https://www.nextmsc.com/report/vital-organs-support-systems-and-medical-bionics-marketTop Companies: Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Cochlear Ltd., Boston Scientific Corporation, Jarvik Heart, Inc., Edwards Lifesciences Corporation, Össur Americas, Inc., Medtronic Plc., SynCardia Systems LLC and others.The global vital organs support systems and medical bionics market share has been analyzed based on vital organ support systems, medical bionics, end user and geography.

Based on vital organ support systems, the market is segmented into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver.

The ear bionics segment is sub segmented into cochlear implants, bone anchored hearing systems, and auditory brainstem implants.

Based on target disease, the vital organs support systems and medical bionics market is divided into hospitals, ambulatory surgical centers, and others.

Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.Request sample copy of this report at:-https://www.nextmsc.com/vital-organs-support-systems-and-medical-bionics-market/request-sampleNorth America is expected to maintain its dominance in the global vital organs support systems and medical bionics market, owing to the presence of developed economies and increased adoption of vital organs support systems and medical bionics in this region.

Medical Bionic Implant/Artificial Organs Market OverviewA bionic implant is an artificially engineered device that is implanted to replace a natural organ in a human, with the purpose to provide life support while awaiting a transplant and improves a patient's ability to interact socially.According to the report published by Market Research Future (MRFR), the global medical bionic implant/artificial organs market is anticipated to grow exponentially and register a CAGR of 7.0% over the forecast period of 2018 to 2023.The growing cases of organ failure have improved the demand for replaceable organs, which contributes to the market growth of the medical bionic implant/artificial organs market to a great extent.

The prevalence of organ failure is found to be more common among the elderly consumers, as they are more vulnerable towards health issues such as gastrointestinal problems, ophthalmic diseases, cancer, orthopedic diseases, among others.

Other influential factors such as technological advancements, a growing number of accidents and injuries, improving the government regulatory framework and assistance, and the increasing prevalence of eye diseases are constantly contributing to create growth in the global medical bionic implant/artificial organs market.Despite these positive factors, issues connected with the medical bionic implant/artificial organs market are lack of skilled professionals, the high expenditure on devices, risk of malfunction of devices, and the comparatively poor healthcare system in low and middle-income countries may obstruct the growth of the market to an extent.Medical Bionic Implant/Artificial Organs Market Segmental AnalysisThe market for global medical bionic implant/artificial organs is segmented by technology, product, fixation, end-user, and region.Based on technology, the market is bifurcated as mechanical bionics and electronic bionics.Based on the product, the market is classified as vision bionics, orthopedic bionics, ear bionics, neural/brain bionics, heart bionics, and others.

Ear bionics are further segmented as Bone Anchored Hearing Aid (BAHA) and cochlear implant.

Orthopedic bionics is sub-segmented as an exoskeleton, bionic leg, bionic hand, bionic finger, and electrical bone growth stimulators.

The sub-segments of the bionic leg include bionic knee and bionic feet.